We speculate that the release of the immunosuppression that had been induced by the PD-1/PD-L1 interaction would give rise to the activation of a remaining pool of naïve CD4+ cells and the subsequent enhancement of the anti-tumor immune activity. This evidence concerns the gene PDCD1 and neoplasm.